Pharmacogenetic determinants of anti-cancer drug activity and toxicity

Author： Danesi R.   De Braud F.   Fogli S.   Di Paolo A.   Del Tacca M.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.8, 2001-08, pp. : 420-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2710-2718

Bentham Science Publishers

Access to resources Recommend Favorite

Valproic Acid As Anti-Cancer Drug

By  

Current Pharmaceutical Design, Vol. 13, Iss. 33, 2007-11 ,pp. : 3378-3393

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 932-943

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

By Cortejoso Lucía   López-Fernández Luis A  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1173-1191

Future Medicine

Access to resources Recommend Favorite